🇺🇸 FDA
Patent

US 9610338

Serologic correlates of protection against bacillus anthracis infection

granted A61KA61K2039/575A61K39/07

Quick answer

US patent 9610338 (Serologic correlates of protection against bacillus anthracis infection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/575, A61K39/07, A61P, A61P31/04